1. Home
  2. HSAI vs FOLD Comparison

HSAI vs FOLD Comparison

Compare HSAI & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSAI
  • FOLD
  • Stock Information
  • Founded
  • HSAI 2014
  • FOLD 2002
  • Country
  • HSAI China
  • FOLD United States
  • Employees
  • HSAI N/A
  • FOLD N/A
  • Industry
  • HSAI
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSAI
  • FOLD Health Care
  • Exchange
  • HSAI Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • HSAI 2.8B
  • FOLD 2.9B
  • IPO Year
  • HSAI 2023
  • FOLD 2007
  • Fundamental
  • Price
  • HSAI $22.50
  • FOLD $6.41
  • Analyst Decision
  • HSAI Strong Buy
  • FOLD Buy
  • Analyst Count
  • HSAI 1
  • FOLD 10
  • Target Price
  • HSAI $29.30
  • FOLD $16.22
  • AVG Volume (30 Days)
  • HSAI 3.3M
  • FOLD 5.5M
  • Earning Date
  • HSAI 08-18-2025
  • FOLD 08-07-2025
  • Dividend Yield
  • HSAI N/A
  • FOLD N/A
  • EPS Growth
  • HSAI N/A
  • FOLD N/A
  • EPS
  • HSAI N/A
  • FOLD N/A
  • Revenue
  • HSAI $309,148,901.00
  • FOLD $543,141,000.00
  • Revenue This Year
  • HSAI $62.24
  • FOLD $19.84
  • Revenue Next Year
  • HSAI $44.69
  • FOLD $23.18
  • P/E Ratio
  • HSAI N/A
  • FOLD N/A
  • Revenue Growth
  • HSAI 24.20
  • FOLD 28.25
  • 52 Week Low
  • HSAI $3.52
  • FOLD $5.51
  • 52 Week High
  • HSAI $24.18
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • HSAI 60.71
  • FOLD 61.21
  • Support Level
  • HSAI $20.36
  • FOLD $5.66
  • Resistance Level
  • HSAI $23.38
  • FOLD $5.99
  • Average True Range (ATR)
  • HSAI 1.56
  • FOLD 0.20
  • MACD
  • HSAI 0.21
  • FOLD 0.09
  • Stochastic Oscillator
  • HSAI 90.05
  • FOLD 99.99

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: